ARMATA PHARMACEUTICALS, INC. Fair Value Adjustment of Warrants
ARMATA PHARMACEUTICALS, INC. (ARMP) reported Fair Value Adjustment of Warrants of $20.64 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-08-12
- ARMATA PHARMACEUTICALS, INC. fair value adjustment of warrants for the quarter ending 2026-06-30 was $0.00.
- ARMATA PHARMACEUTICALS, INC. fair value adjustment of warrants for the quarter ending 2026-03-31 was $20.64M.
- ARMATA PHARMACEUTICALS, INC. fair value adjustment of warrants for the quarter ending 2018-12-31 was $0.00.
- ARMATA PHARMACEUTICALS, INC. fair value adjustment of warrants for the quarter ending 2018-09-30 was $0.00.
- ARMATA PHARMACEUTICALS, INC. fair value adjustment of warrants for fiscal 2018 was $184.00K.
- ARMATA PHARMACEUTICALS, INC. fair value adjustment of warrants for fiscal 2017 was -$119.00K.
- ARMATA PHARMACEUTICALS, INC. fair value adjustment of warrants for fiscal 2014 was $0.00.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 3 month as first filed | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month | Fair Value Adjustment of Warrants 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $20.64M 10-Q · filed 2026-08-12 | ||||
| 2026-03-31 | $20.64M 10-Q · filed 2026-05-13 | |||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25 | $0.00 derived: sum of 2 quarters · filed 2019-03-25 | $0.00 derived: sum of 3 quarters · filed 2019-03-25 | $184.00K 10-K · filed 2019-03-25 | ||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $0.00 derived: sum of 2 quarters · filed 2018-11-08 | $184.00K 10-Q · filed 2018-11-08 | $41.00K derived: sum of 4 quarters · filed 2018-11-08 | ||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $184.00K 10-Q · filed 2018-08-09 | $41.00K derived: sum of 3 quarters · filed 2018-08-09 | |||
| 2018-03-31 | $184.00K 10-Q · filed 2018-05-15 | $41.00K derived: sum of 2 quarters · filed 2018-05-15 | ||||
| 2017-12-31 | -$143.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | -$119.00K 10-K · filed 2018-03-14 | ||||
| 2017-09-30 | $24.00K 10-Q · filed 2017-11-14 | |||||
| 2015-03-31 | $213.00K 10-Q · filed 2015-05-15 | $213.00K derived: sum of 2 quarters · filed 2015-05-15 | $213.00K derived: sum of 3 quarters · filed 2015-05-15 | $213.00K derived: sum of 4 quarters · filed 2015-05-15 | ||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2015-04-15 | $0.00 derived: sum of 2 quarters · filed 2015-04-15 | $0.00 derived: sum of 3 quarters · filed 2015-04-15 | $0.00 10-K · filed 2015-04-15 | ||
| 2014-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2015-04-15 | $0.00 derived: sum of 2 quarters · filed 2015-04-15 | $0.00 10-Q/A · filed 2015-04-15 | $9.17M derived: sum of 4 quarters · filed 2015-05-15 | ||
| 2014-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2015-04-15 | $0.00 10-Q/A · filed 2015-04-15 | $9.17M derived: sum of 3 quarters · filed 2015-05-15 | $9.17M derived: sum of 4 quarters · filed 2015-05-15 | ||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-15 | $2.26M 10-Q · filed 2014-05-20 | $9.17M derived: sum of 2 quarters · filed 2015-05-15 | $9.17M derived: sum of 3 quarters · filed 2015-05-15 | ||
| 2013-12-31 | $9.17M derived: 10-Q/A 12 month − 10-Q/A 9 month · filed 2015-04-15 | $9.17M derived: sum of 2 quarters · filed 2015-04-15 | $9.93M 10-Q/A · filed 2015-04-15 | $10.28M 10-Q · filed 2014-09-12 | ||
| 2013-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2015-04-15 | $759.00K 10-Q/A · filed 2015-04-15 | ||||
| 2013-06-30 | $759.00K 10-Q/A · filed 2015-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |